Invention Grant
- Patent Title: Modulation of huntingtin expression
-
Application No.: US15596249Application Date: 2017-05-16
-
Publication No.: US10202603B2Publication Date: 2019-02-12
- Inventor: Gene Hung , C. Frank Bennett , Susan M. Freier , Holly Kordasiewicz , Lisa Stanek , Don W. Cleveland , Seng H. Cheng , Lamya Shihabuddin
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of huntingtin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate Huntington's disease, or a symptom thereof.
Public/Granted literature
- US20180087052A1 MODULATION OF HUNTINGTIN EXPRESSION Public/Granted day:2018-03-29
Information query
